CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

VisionSys AI Inc

VSA
$6MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for VSA. That does not mean none is planned.

Get an email about VSA's next catalysts

Track VisionSys AI (VSA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQServices-Educational Services🇺🇸North AmericaNEW YORK3.9K employees

Frequently asked questions

What is in VisionSys AI Inc's drug pipeline?→

CatalystAlert tracks 4 drug candidates in VisionSys AI Inc's (VSA) pipeline across Phase 3, Phase 2. Its lead program is Rebamipide ophthalmic (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is VisionSys AI Inc's next FDA catalyst?→

CatalystAlert tracks every upcoming catalyst for VisionSys AI Inc (VSA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track VSA biotech catalysts?→

Add VSA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow VisionSys AI Inc's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply